BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 74 found
  Current Search:  herpes: 74     

HTML
100%
Ark files malignant glioma drug Cerepro with EMEA
Ark Therapeutics Group has refiled its gene-based brain cancer drug Cerepro with regulators in Europe.

The London-headquartered group has submitted a marketing authorisation application for Cerepro (adenovirus-mediated Herpes simplex...

Pharma Times:  Dec 2 2008 11:54AM
Matching: herpes
Find similar documents
HTML
100%
East London Getting Sexual Health Clinic Test Results By Text On Their Mobile Phones
Sexual Health / STDs News Main Category: Sexual Health / STDs email to a friend printer friendly view / write opinions rate article Current Article Ratings: Patient / Public: Health Professional: Article Opinions: Patients in East London are...
Medical News Today:  Dec 1 2008 2:34PM
Matching: herpes
Find similar documents
HTML
100%
Herpes drug inhibits HIV replication, but with a price
The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC.

This beneficial effect does pose a risk though, as HIV-infected cells...

Therapeutics Daily:  Nov 26 2008 1:29PM
Matching: herpes
Find similar documents
HTML
100%
HIV/AIDS Co-Infection - Recent findings in HIV/AIDS co-infection described by F.M. Cowan and colleagues
According to recent research from London, the United Kingdom, ' To assess the effectiveness of a community-based prevention intervention for adolescents in terms of its impact on (1) HIV and Herpes simplex type 2 (HSV-2) incidence and...
NewsRX:  Nov 23 2008 1:12AM
Matching: herpes
Find similar documents
HTML
100%
New HIV/AIDS co-infection study results from Federal University described
- (NewsRx.com) -- 'The synthetic n-alkyl esters of gallic acid (GA), also known as gallates, especially propyl, octyl and dodecyl gallates, are widely employed as antioxidants by food and pharmaceutical industries (see also HIV/AIDS Co...
Calibre Macro World:  Nov 21 2008 1:54AM
Matching: herpes
Find similar documents
HTML
100%
Recent findings in HIV/AIDS co-infection described by F.M. Cowan and colleagues
- (NewsRx.com) -- According to recent research from London, the United Kingdom, ' To assess the effectiveness of a community-based HIV prevention intervention for adolescents in terms of its impact on (1) HIV and Herpes simplex virus...
Calibre Macro World:  Nov 21 2008 1:41AM
Matching: herpes
Find similar documents
HTML
100%
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, H
- (NewsRx.com) -- (Profectus) announced that it has executed an Assignment and License Agreement with Wyeth Pharmaceuticals that provides Profectus therapeutic/prophylactic vaccine programs for Human Immunodeficiency Virus (HIV), Hepatitis C...
Therapeutics Daily:  Nov 20 2008 10:31PM
Matching: herpes
Find similar documents
HTML
100%
Herpes Drug Inhibits HIV Replication, But With A Price
ScienceDaily (Nov.

15, 2008) The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC.

This beneficial effect does pose a risk...

Science Daily:  Nov 16 2008 1:21PM
Matching: herpes
Find similar documents
HTML
100%
Herpes Vaccine Can Protect Men, Study Suggests
ATLANTA - For the first time, an expensive vaccine aimed at preventing cervical has proven successful at preventing a disease in men, a study released Thursday by the vaccine's maker said.

The disease is genital warts - sexually...

Tampa Tribune:  Nov 14 2008 9:14AM
Matching: herpes
Find similar documents
HTML
100%
Profectus Biosciences Executes an Assignment and License Agreement with Wyeth Pharmaceuticals
- Profectus BioSciences, Inc.

(Profectus) announced today that it has executed an Assignment and License Agreement with Wyeth Pharmaceuticals that provides Profectus therapeutic/prophylactic vaccine programs for Human Immunodeficiency...

Pharma Live:  Nov 11 2008 9:36PM
Matching: herpes
Find similar documents
HTML
100%
Association Found between Epstein-Barr Virus and Some Inflammatory Mouth Disease
A significant percentage of dental patients with irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus, according to researchers at Oregon Health & Science University's (OHSU) School of Dentistry.
Genetic Engineering News:  Nov 11 2008 4:18PM
Matching: herpes
Find similar documents
HTML
100%
Mount Sinai Medical Center
And Dartmouth College Studies: Elderly Fare Well In Open-Heart Surgery 11/11/2008 6:24:33 AM More...

Mount Sinai Medical CenterRelease: Drug Effective In Treatment of Heavy Psoriasis Patients 8/3/2007 12:08:15 PM More...

Immune Signals...

BioSpace:  Nov 11 2008 3:33PM
Matching: herpes
Find similar documents
HTML
100%
Epstein-Barr virus linked to inflammatory diseases of the mouth
Medical Research News Researchers at have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.

The Epstein-Barr virus is an...

News-Medical.Net:  Nov 11 2008 2:16PM
Matching: herpes
Find similar documents
HTML
100%
TopAbstracts in Viral Infections 11/10/2008
TopAbstracts in Viral Infections are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.

Over 2000 peer...

Doctors Guide:  Nov 11 2008 1:38PM
Matching: herpes
Find similar documents
HTML
100%
Study Finds Association Between Epstein-Barr, Inflammatory Diseases of the Mouth
-- Researchers have found that a significant percentage of dental patients irreversible pulpitis and apical periodontitis also have the Epstein-Barr virus.

The study was published early online and will appear in the December 2008 issue of...

Doctors Guide:  Nov 11 2008 1:37PM
Matching: herpes
Find similar documents
HTML
100%
Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis
Title: United States Patent: 7,442,688 Inventors: Zoghbi; Huda Y.

(Houston, TX), Bellen; Hugo (Houston, TX), Bermingham; Nessan (Houston, TX), Hassan; Bassem (Houston, TX), Ben-arie; Nissim (Jerusalem, IL) Assignee: Baylor College of...

PharmCast:  Nov 11 2008 1:16PM
Matching: herpes
Find similar documents
HTML
100%
::: Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HC
Leading R&D Company Will Continue Research for Both Therapeutic and Preventative Vaccines of Chronic Viral Diseases Profectus BioSciences, Inc.

(Profectus) announced today that it has executed an Assignment and License Agreement with...

Biotech Intelligence:  Nov 11 2008 2:04AM
Matching: herpes
Find similar documents
HTML
100%
Herpes Drug Inhibits HIV Replication
The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC.

This beneficial effect does pose a risk though, as HIV-infected cells...

Drug Discovery and Development:  Nov 11 2008 12:55AM
Matching: herpes
Find similar documents
HTML
100%
Epstein-Barr Virus Associated With Inflammatory Diseases Of The Mouth
ScienceDaily (Nov.

10, 2008) Researchers at Oregon Health & Science University's School of Dentistry have found that a significant percentage of dental patients with the inflammatory diseases irreversible pulpitis and apical...

Science Daily:  Nov 11 2008 12:36AM
Matching: herpes
Find similar documents
HTML
100%
CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vac
- Profectus BioSciences Jeff Meshulam, 443-743-1107 meshulam@profectusbiosciences.com or Garfield Group Kevin Jurrens, 215-867-8600 (x273) Public Relations kjurrens@garfieldgroup.com Contact phone number for Jeff Meshulam is 443-743-1107 ...
PR inside:  Nov 10 2008 10:18PM
Matching: herpes
Find similar documents
HTML
100%
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV, H
- Leading R&D Company Will Continue Research for Both Therapeutic and Preventative Vaccines of Chronic Viral Diseases Profectus BioSciences, Inc.

(Profectus) announced today that it has executed an Assignment and License Agreement with...

Pharma Live:  Nov 10 2008 10:16PM
Matching: herpes
Find similar documents
HTML
100%
Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vaccines against HIV, HCV,
- Profectus BioSciences Jeff Meshulam, 443-543-5010 meshulam@profectusbiosciences.com or Garfield Group Kevin Jurrens, 215-867-8600 (x273) Public Relations kjurrens@garfieldgroup.com Profectus BioSciences, Inc.

(Profectus) announced today...

PR inside:  Nov 10 2008 7:14PM
Matching: herpes
Find similar documents
HTML
100%
CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vac
Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010).

The corrected release reads: PROFECTUS BIOSCIENCES EXECUTES AN ASSIGNMENT AND LICENSE AGREEMENT WITH WYETH FOR VACCINES AGAINST HIV, HCV, HPV AND HSV Leading R&...

Genetic Engineering News:  Nov 10 2008 6:29PM
Matching: herpes
Find similar documents
HTML
100%
CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vac
Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010).

The corrected release reads: PROFECTUS BIOSCIENCES EXECUTES AN ASSIGNMENT AND LICENSE AGREEMENT WITH WYETH FOR VACCINES AGAINST HIV, HCV, HPV AND HSV Leading R&...

Forbes.com:  Nov 10 2008 5:47PM
Matching: herpes
Find similar documents
HTML
100%
CORRECTING and REPLACING Profectus BioSciences Executes an Assignment and License Agreement with Wyeth for Vac
BALTIMORE--(BUSINESS WIRE)--Contact phone number for Jeff Meshulam is 443-743-1107 (sted 443-543-5010).The corrected release reads:PROFECTUS BIOSCIENCES EXECUTES AN ASSIGNMENT AND LICENSE AGREEMENT WITH WYETH FOR VACCINES AGAINST HIV, HCV,...
Yahoo! Canada:  Nov 10 2008 5:18PM
Matching: herpes
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.